NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Aug 11, 2021 $1.54 -1.28% $1.56 X 98.72% 2
Jackeline Picasso Jackeline Picasso @JackelinePicasso.175458
Aug 11, 2021 Bearish $1.56 X 1
JS JS Pro
Feb 10, 2021 $2.50 -8.76% $2.74 X 91.24% 0
Shilkoff Andrey Shilkoff Andrey @ShilkoffAndrey.205243
Feb 10, 2021 $2.67 -2.55% $2.74 X 97.45% 0
JS JS Pro
Nov 30, 2020 $1.41 +4.44% $1.35 X 95.56% 0
mirko Digia mirko Digia @mirkoDigia.179567
Nov 30, 2020 Bullish $1.35 X 0
Alan Alan Pro @Alan.115878
Nov 30, 2020 $1.44 +6.67% $1.35 X 93.33% 0
JS JS Pro
Nov 23, 2020 $1.44 +5.11% $1.37 X 94.89% 1
JS JS Pro
Nov 20, 2020 $1.46 +0.69% $1.45 X 99.31% 4
JS JS Pro
Oct 30, 2020 $1.38 +1.85% $1.35 X 98.15% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE